Correlation Between Gilead Sciences and MERCK Kommanditgesells

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Gilead Sciences and MERCK Kommanditgesells at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gilead Sciences and MERCK Kommanditgesells into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Gilead Sciences and MERCK Kommanditgesellschaft auf, you can compare the effects of market volatilities on Gilead Sciences and MERCK Kommanditgesells and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gilead Sciences with a short position of MERCK Kommanditgesells. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gilead Sciences and MERCK Kommanditgesells.

Diversification Opportunities for Gilead Sciences and MERCK Kommanditgesells

-0.29
  Correlation Coefficient

Very good diversification

The 3 months correlation between Gilead and MERCK is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Gilead Sciences and MERCK Kommanditgesellschaft au in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MERCK Kommanditgesells and Gilead Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gilead Sciences are associated (or correlated) with MERCK Kommanditgesells. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MERCK Kommanditgesells has no effect on the direction of Gilead Sciences i.e., Gilead Sciences and MERCK Kommanditgesells go up and down completely randomly.

Pair Corralation between Gilead Sciences and MERCK Kommanditgesells

Given the investment horizon of 90 days Gilead Sciences is expected to generate 5.99 times less return on investment than MERCK Kommanditgesells. But when comparing it to its historical volatility, Gilead Sciences is 2.18 times less risky than MERCK Kommanditgesells. It trades about 0.05 of its potential returns per unit of risk. MERCK Kommanditgesellschaft auf is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  14,205  in MERCK Kommanditgesellschaft auf on October 20, 2024 and sell it today you would earn a total of  770.00  from holding MERCK Kommanditgesellschaft auf or generate 5.42% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.0%
ValuesDaily Returns

Gilead Sciences  vs.  MERCK Kommanditgesellschaft au

 Performance 
       Timeline  
Gilead Sciences 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Gilead Sciences are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating essential indicators, Gilead Sciences may actually be approaching a critical reversion point that can send shares even higher in February 2025.
MERCK Kommanditgesells 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days MERCK Kommanditgesellschaft auf has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Gilead Sciences and MERCK Kommanditgesells Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Gilead Sciences and MERCK Kommanditgesells

The main advantage of trading using opposite Gilead Sciences and MERCK Kommanditgesells positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gilead Sciences position performs unexpectedly, MERCK Kommanditgesells can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MERCK Kommanditgesells will offset losses from the drop in MERCK Kommanditgesells' long position.
The idea behind Gilead Sciences and MERCK Kommanditgesellschaft auf pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Complementary Tools

Bonds Directory
Find actively traded corporate debentures issued by US companies
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk